DYNC1H1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.97459842815806E-14 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.09250000554806E-08 |
Normal-vs-Stage2 |
3.785600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.722200E-03 |
Stage1-vs-Stage2 |
5.507800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.367600E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.688400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.92312873695755E-12 |
Normal-vs-AfricanAmerican |
2.095600E-01 |
Normal-vs-Asian |
1.811680E-02 |
Caucasian-vs-AfricanAmerican |
1.026550E-01 |
Caucasian-vs-Asian |
2.824400E-01 |
AfricanAmerican-vs-Asian |
5.539200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.05409999998185E-06 |
Normal-vs-Female |
7.69849994863847E-09 |
Male-vs-Female |
5.341400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.642000E-04 |
Normal-vs-Extreme_Weight |
7.42019999999677E-07 |
Normal-vs-Obese |
2.157000E-04 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.963600E-01 |
Normal_Weight-vs-Obese |
1.358430E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.649940E-02 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.082500E-02 |
Normal-vs-Age(41-60Yrs) |
1.031220E-04 |
Normal-vs-Age(61-80Yrs) |
4.75369998920172E-09 |
Normal-vs-Age(81-100Yrs) |
3.697200E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.368000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.192000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.489410E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.426200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.870200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.045200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.107600E-01 |
Normal-vs-Grade 3 |
1.078810E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
4.399800E-01 |
Grade 2-vs-Grade 4 |
3.107600E-01 |
Grade 3-vs-Grade 4 |
1.078810E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.01220040629835E-10 |
Normal-vs-N1 |
4.784400E-03 |
N0-vs-N1 |
3.145200E-01 |
|
|